Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-12-12

Clinical Trial Update: Patient-specific, Effective, and Rational Functional Connectivity Targeting for DBS in OCD

View source ↗

Summary

A clinical trial evaluating patient-specific functional connectivity targeting for deep brain stimulation in obsessive-compulsive disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Obsessive-Compulsive Disorder | Status: WITHDRAWN